Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cytochromes are a diverse group of heme-containing proteins essential for the respiratory electron transport chain in bacteria. They function as oxidoreductases, facilitating electron transfer from substrates like quinols to terminal acceptors such as oxygen, which drives the generation of a proton motive force for ATP synthesis. In many pathogens, including Mycobacterium tuberculosis, the respiratory chain utilizes two primary terminal oxidases: the cytochrome bc1-aa3 supercomplex and the cytochrome bd oxidase. These enzymes are critical for bacterial adaptation to environmental stressors, such as hypoxia and host-derived oxidative or nitrosative stress. Because certain bacterial cytochromes, particularly the bd-type, are absent in humans or structurally distinct from human mitochondrial counterparts, they are highly attractive targets for selective antimicrobial therapy. Drugs like telacebec (Q203) specifically inhibit the bc1 complex, while inhibitors of the bd oxidase are being developed to overcome functional redundancy and achieve bactericidal effects. Additionally, bacterial cytochrome P450 enzymes are targets for azole-based drugs, further highlighting the therapeutic importance of this protein class. Overall, targeting bacterial cytochromes disrupts cellular energy production and stress resistance, making them vital components in the development of next-generation antibiotics.
Inhibition of the bacterial respiratory electron transport chain by blocking quinol oxidation or oxygen reduction, leading to ATP depletion and bacterial cell death.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cytochrome (Cyt).